NORTH CHICAGO, U.S.A., February 21,
2017 /PRNewswire/ --
AbbVie Inc. (&abcz;AbbVie&abcz;) (NYSE / CHX / Euronext
Paris / SIX: ABBV) today informs its stockholders that it has filed
an Annual Report on Form 10-K for the fiscal year ended
December 31, 2016 with the U.S.
Securities and Exchange Commission (&abcz;SEC&abcz;).
AbbVie makes available free of charge on its website its Annual
Report on Form 10-K, Quarterly Reports on Form 10-Q, Current
Reports on Form 8-K, reports filed pursuant to Section 16 of the
U.S. Securities Exchange Act of 1934 and amendments to those
reports filed with or furnished to the SEC as soon as reasonably
practicable after AbbVie electronically files these documents with,
or furnishes them to, the SEC. These documents are posted on
AbbVie's website at www.abbvieinvestor.com.
The SEC maintains a website that contains reports, proxy
statements and other information regarding issuers that file
electronically with the SEC. These materials may be obtained
electronically by accessing the SEC's home page at
http://www.sec.gov.
Copies of the above referenced information will also be made
available, free of charge, upon written request to AbbVie Inc.,
Investors Relations, 1 North Waukegan Road, North Chicago, Illinois 60064, U.S.A.
This is a disclosure announcement from PR Newswire.